drugs

Business

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to

Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription

Read More
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from

Read More
Business

Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock falls 18%

Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies

Read More
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for

Read More
Business

Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov.

Read More
Earnings

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing

A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish

Read More
Business

Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs

A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said it will

Read More

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.